Wikipedia:Articles for deletion/Neuronetrix


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was   delete. slakr \ talk / 13:57, 18 February 2014 (UTC)

Neuronetrix

 * – ( View AfD View log  Stats )

Their only product is not yet in the market. Nonetheless the articles lists all the officers of the firm, all the general topics related to it, and, for references, quite a few press releases.  DGG ( talk ) 06:49, 1 February 2014 (UTC)
 * Note: This debate has been included in the list of Kentucky-related deletion discussions. • Gene93k (talk) 17:28, 1 February 2014 (UTC)
 * Note: This debate has been included in the list of Business-related deletion discussions. • Gene93k (talk) 17:28, 1 February 2014 (UTC)
 * Note: This debate has been included in the list of Medicine-related deletion discussions. • Gene93k (talk) 17:28, 1 February 2014 (UTC)


 * Well, as explains, it can take a long time for healthcare start-up to make or break. I can't find any coverage of how the trials ended, although it looks like they should have ended by now. It seems to have only local press coverage, so unless someone finds something spectacular about them, I think they fail WP:CORP, so delete. Someone not using his real name (talk) 17:04, 8 February 2014 (UTC)
 * Relisted to generate a more thorough discussion so a clearer consensus may be reached.


 * Please add new comments below this notice. Thanks, Northamerica1000(talk) 08:38, 9 February 2014 (UTC)


 * Delete - Fails Notability (organizations and companies), the applicable guideline, due to a lack of depth of coverage and independence of sources. The sources are press releases. -   t  u coxn \ talk 03:38, 16 February 2014 (UTC)
 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.